New Battle In “Gendicine” Gene Therapy Patent War Begins
This article was originally published in PharmAsia News
Executive SummaryA new battle in the Gendicine gene therapy patent war recently began, but this time in an American courtroom
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.